246 related articles for article (PubMed ID: 19821205)
1. A patient with nonfunctional pancreatic neuroendocrine tumor and incidental metachronous colon carcinoma detected by positron emission tomography: case report.
Demirkan B; Unek IT; Eriksson B; Akarsu M; Durak H; Sağol O; Obuz F; Binicier C; Füzün M; Alakavuklar M
Turk J Gastroenterol; 2009 Sep; 20(3):214-9. PubMed ID: 19821205
[TBL] [Abstract][Full Text] [Related]
2. PET-Computed Tomography and Precision Medicine in Pancreatic Adenocarcinoma and Pancreatic Neuroendocrine Tumors.
Pinho DF; Subramaniam RM
PET Clin; 2017 Oct; 12(4):407-421. PubMed ID: 28867112
[No Abstract] [Full Text] [Related]
3. Multidisciplinary management of nonfunctional neuroendocrine tumor of the pancreas.
Folkert IW; Hernandez P; Roses RE
World J Gastroenterol; 2016 Mar; 22(11):3105-16. PubMed ID: 27003988
[TBL] [Abstract][Full Text] [Related]
4. Nonfunctional Pancreatic Neuroendocrine Tumors: Advances in Diagnosis, Management, and Controversies.
Dumlu EG; Karakoç D; Özdemir A
Int Surg; 2015 Jun; 100(6):1089-97. PubMed ID: 25590518
[TBL] [Abstract][Full Text] [Related]
5. Hyperaccumulation of (18)F-FDG in order to differentiate solid pseudopapillary tumors from adenocarcinomas and from neuroendocrine pancreatic tumors and review of the literature.
Guan ZW; Xu BX; Wang RM; Sun L; Tian JH
Hell J Nucl Med; 2013; 16(2):97-102. PubMed ID: 23687644
[TBL] [Abstract][Full Text] [Related]
6. [Pancreatic neuroendocrine neoplasms].
Beiderwellen K; Sabet A; Lauenstein TC; Lahner H; Poeppel TD
Radiologe; 2016 Apr; 56(4):348-54. PubMed ID: 27003413
[TBL] [Abstract][Full Text] [Related]
7. Positron-emission tomography as a radiological technique in neuroendocrine gastrointestinal tumors.
Eriksson B; Lilja A; Ahlström H; Bjurling P; Bergström M; Lindner KJ; Långström B; Oberg K
Ann N Y Acad Sci; 1994 Sep; 733():446-52. PubMed ID: 7978893
[No Abstract] [Full Text] [Related]
8. Impact of F18-fluorodeoxyglycose positron emission tomography/computed tomography on the management of resectable pancreatic tumours.
Yao J; Gan G; Farlow D; Laurence JM; Hollands M; Richardson A; Pleass HC; Lam VW
ANZ J Surg; 2012 Mar; 82(3):140-4. PubMed ID: 22510123
[TBL] [Abstract][Full Text] [Related]
9. Evaluation and Management of Neuroendocrine Tumors of the Pancreas.
Scott AT; Howe JR
Surg Clin North Am; 2019 Aug; 99(4):793-814. PubMed ID: 31255207
[TBL] [Abstract][Full Text] [Related]
10. Current knowledge on the sensitivity of the (68)Ga-somatostatin receptor positron emission tomography and the SUVmax reference range for management of pancreatic neuroendocrine tumours.
Virgolini I; Gabriel M; Kroiss A; von Guggenberg E; Prommegger R; Warwitz B; Nilica B; Roig LG; Rodrigues M; Uprimny C
Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):2072-83. PubMed ID: 27174220
[TBL] [Abstract][Full Text] [Related]
11. [Well-differentiated neuroendocrine tumors of the digestive tract: Focus on pancreatic neuroendocrine tumors].
Pellat A; Barat M; Cottereau AS; Terris B; Coriat R
Bull Cancer; 2023 Sep; 110(9):955-967. PubMed ID: 36935319
[TBL] [Abstract][Full Text] [Related]
12. A case of metachronous double primary neuroendocrine cancer in pancreas/ileum and uterine cervix.
Sisti G; Buccoliero AM; Novelli L; Sansovini M; Severi S; Pieralli A; Livi L; Fambrini M
Ups J Med Sci; 2012 Nov; 117(4):453-6. PubMed ID: 23009225
[TBL] [Abstract][Full Text] [Related]
13. Differential uptake of (68)Ga-DOTATOC and (68)Ga-DOTATATE in PET/CT of gastroenteropancreatic neuroendocrine tumors.
Poeppel TD; Binse I; Petersenn S; Lahner H; Schott M; Antoch G; Brandau W; Bockisch A; Boy C
Recent Results Cancer Res; 2013; 194():353-71. PubMed ID: 22918768
[TBL] [Abstract][Full Text] [Related]
14. Islet Cell Tumors of the Pancreas.
Amin S; Kim MK
Gastroenterol Clin North Am; 2016 Mar; 45(1):83-100. PubMed ID: 26895682
[TBL] [Abstract][Full Text] [Related]
15. Molecular imaging of late somatostatin receptor-positive metastases of renal cell carcinoma in the pancreas by 68Ga DOTATOC PET/CT: a rare differential diagnosis to multiple primary pancreatic neuroendocrine tumors.
Peter L; Sänger J; Hommann M; Baum RP; Kaemmerer D
Clin Nucl Med; 2014 Aug; 39(8):713-6. PubMed ID: 24561680
[TBL] [Abstract][Full Text] [Related]
16. Observational study of natural history of small sporadic nonfunctioning pancreatic neuroendocrine tumors.
Gaujoux S; Partelli S; Maire F; D'Onofrio M; Larroque B; Tamburrino D; Sauvanet A; Falconi M; Ruszniewski P
J Clin Endocrinol Metab; 2013 Dec; 98(12):4784-9. PubMed ID: 24057286
[TBL] [Abstract][Full Text] [Related]
17. Non-functional neuroendocrine tumors of the pancreas: Advances in diagnosis and management.
Cloyd JM; Poultsides GA
World J Gastroenterol; 2015 Aug; 21(32):9512-25. PubMed ID: 26327759
[TBL] [Abstract][Full Text] [Related]
18. The diagnosis and medical management of advanced neuroendocrine tumors.
Kaltsas GA; Besser GM; Grossman AB
Endocr Rev; 2004 Jun; 25(3):458-511. PubMed ID: 15180952
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma and gastroenteropancreatic neuroendocrine tumors: potential role of other positron emission tomography radiotracers.
Jadvar H
Semin Nucl Med; 2012 Jul; 42(4):247-54. PubMed ID: 22681673
[TBL] [Abstract][Full Text] [Related]
20. Molecular imaging of gastroenteropancreatic neuroendocrine tumors.
Miederer M; Weber MM; Fottner C
Gastroenterol Clin North Am; 2010 Dec; 39(4):923-35. PubMed ID: 21093764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
